Bispecific single chain Fv antibody molecules and methods of use therof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8980258
APP PUB NO 20130202603A1
SERIAL NO

13710146

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Bispecific single chain antibody molecules are disclosed which may be used to advantage to treat various forms of cancer associated with the overexpression of members of the EGFR protein family.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE INSTITUTE FOR CANCER RESEARCH333 COTTMAN AVENUE PHILADELPHIA PA 19111

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Adams, Gregory P Hatboro, US 15 422
Horak, Eva M West Orange, US 5 345
Marks, James D Kensington, US 85 1535
Weiner, Louis M Washington, US 16 372

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 17, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00